Altamira Revenue and Competitors

Texas, USA

Location

N/A

Total Funding

Energy/Oil

Industry

Estimated Revenue & Valuation

  • Altamira's estimated annual revenue is currently $26.7M per year.(i)
  • Altamira's estimated revenue per employee is $245,000

Employee Data

  • Altamira has 109 Employees.(i)
  • Altamira grew their employee count by 24% last year.

Altamira's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP Sales MarketingReveal Email/Phone
3
Senior Project ManagerReveal Email/Phone
4
Program ManagerReveal Email/Phone
5
Sr Project ManagerReveal Email/Phone
6
Program ManagerReveal Email/Phone
7
Senior Project ManagerReveal Email/Phone
8
GIS ManagerReveal Email/Phone
9
Project Manager - IntegrityReveal Email/Phone
10
Air Quality Program ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$23.5M9625%N/AN/A
#2
$248.7M71010%$140MN/A
#3
$34.1M1395%N/AN/A
#4
$32.8M1342%N/AN/A
#5
$61.7M2291%N/AN/A
#6
$32.3M1321%$22.7MN/A
#7
$16.1M73-14%N/AN/A
#8
$645M22-8%N/AN/A
#9
$37.7M1409%N/AN/A
#10
$891M2200%N/AN/A
Add Company

What Is Altamira?

Altamira is your trusted partner in consulting, engineering, and field service support. The combination of our owner's mentality, commitment to hearing your needs and concerns, and delivering with our proven processes help ensure project success. With our regulatory expertise and agile approach, we create working relationships that value compliance and deliver desirable outcomes that bolster your bottom line.

keywords:N/A

N/A

Total Funding

109

Number of Employees

$26.7M

Revenue (est)

24%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Altamira News

2022-04-13 - Altamira Therapeutics Provides Business Update and Reports ...

Altamira Therapeutics Provides Business Update and Reports Second Half and Full Year 2021 Financial Results. Published: Apr 12, 2022. Management will host...

2022-04-13 - Altamira Therapeutics Ltd. (CYTO) CEO Thomas Meyer on Q4 2021 Results - Earnings Call Transcript

Altamira Therapeutics Ltd. (NASDAQ:CYTO) Q4 2021 Earnings Conference Call April 12, 2022 8:00 AM ET. Company Participants.

2022-04-13 - Altamira Therapeutics Reports FY21 Results, Provides ...

?Altamira Therapeutics Ltd (NASDAQ:CYTO) today provided a business update and reported its second half and full 2021 financial results.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$29.5M1496%N/A
#2
$52.5M19114%N/A
#3
$31.3M19621%N/A
#4
$233.4M7944%N/A
#5
$188.4M92825%N/A